Journal Logo

October 2019 - Volume 29 - Issue 5
pp: 453-559

Basic Science

Translational Research

Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma

Johansson, Peter A.; Nathan, Vaishnavi; Bourke, Lauren M.; More

Melanoma Research. 29(5):483-490, October 2019.

Neuroblastoma RAS viral oncogene homolog mRNA is differentially spliced to give five distinct isoforms: implications for melanoma therapy

Duggan, Megan C.; Regan-Fendt, Kelly; Olaverria Salavaggione, Gonzalo N.; More

Melanoma Research. 29(5):491-500, October 2019.

Clinical Research

Effectiveness of dabrafenib in the treatment of patients with BRAF V600–mutated metastatic melanoma in a Named Patient Program

Martin-Algarra, Salvador; Hinshelwood, Rebecca; Mesnage, Soizick; More

Melanoma Research. 29(5):527-532, October 2019.

Basic Science

Semaphorin-5A downregulation is associated with enhanced migration and invasion of BRAF-positive melanoma cells under vemurafenib treatment in melanomas with heterogeneous BRAF status

Komina, Anna V.; Palkina, Nadezhda V.; Aksenenko, Mariya B.; More

Melanoma Research. 29(5):544-548, October 2019.

Clinical Research